Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
eugenio.barone@uniroma1.it
Eugenio Barone
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE BIOCHIMICHE "ALESSANDRO ROSSI FANELLI"
E-mail:
eugenio.barone@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles
ALZHEIMER'S & DEMENTIA
2021
Biliverdin reductase-A protein levels are reduced in type 2 diabetes and are associated with poor glycometabolic control
LIFE SCIENCES
2021
The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease
FREE RADICAL BIOLOGY & MEDICINE
2021
mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder
FREE RADICAL BIOLOGY & MEDICINE
2021
Editorial: Brain insulin resistance in neurodevelopmental and neurodegenerative disorders: mind the gap!
FRONTIERS IN NEUROSCIENCE
2021
Valorization of tomato waste as a source of carotenoids
MOLECULES
2021
Building the future therapies for down syndrome: the third international conference of the T21 research society
MOLECULAR SYNDROMOLOGY
2021
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome
NEUROBIOLOGY OF DISEASE
2020
Heme oxygenase-1 in central nervous system malignancies
JOURNAL OF CLINICAL MEDICINE
2020
Down syndrome Is a metabolic disease: altered Insulin signaling mediates peripheral and brain dysfunctions
FRONTIERS IN NEUROSCIENCE
2020
Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD/NASH in individuals with and without obesity and metabolic disease
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2020
The BACH1/Nrf2 axis in brain in down syndrome and transition to alzheimer disease-like neuropathology and dementia
ANTIOXIDANTS
2020
Chronic perk induction promotes alzheimer-like neuropathology in down syndrome: Insights for therapeutic intervention
PROGRESS IN NEUROBIOLOGY
2020
Reduced biliverdin reductase-a expression in visceral adipose tissue is associated with adipocyte dysfunction and nafld in human obesity
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2020
The dysregulation of OGT/OGA cycle mediates Tau and APP neuropathology in down syndrome
NEUROTHERAPEUTICS
2020
Proteomics study of peripheral blood mononuclear cells in down syndrome children
ANTIOXIDANTS
2020
BVR-A deficiency leads to autophagy impairment through the dysregulation of AMPK/mTOR axis in the brain—Implications for neurodegeneration
ANTIOXIDANTS
2020
Biliverdin reductase-A mediates the beneficial effects of intranasal insulin in Alzheimer disease
MOLECULAR NEUROBIOLOGY
2019
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease
NEUROBIOLOGY OF DISEASE
2019
Reduced biliverdin reductase-a levels are associated with early alterations of insulin signaling in obesity
BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE
2019
« prima
< precedente
1
2
3
4
seguente ›
ultima »
Progetti di Ricerca
ABERRANT INSULIN SIGNALING CONTRIBUTES TO DEVELOPMENT OF ALZHEIMER DISEASE: SEARCH FOR NOVEL THERAPEUTIC STRATEGIES
Biliverdin reductase-A impairment mediates the development of insulin resistance in obesity and T2DM: a novel mechanism of action.
Unravelling a novel mechanism favoring brain insulin resistance development and its impact on Alzheimer disease neuropathology
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma